HemoCept Inc.
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Inclusion Criteria: * Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures. * Subjects can be any gender but must be age 18 or older. * Subject is able and willing to provide informed consent and HIPAA authorization. * Subject is able and willing to meet all study requirements. * Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible) Exclusion Criteria: * Subject is pregnant, breastfeeding, or intends to become pregnant during this study.